Becker's Healthcare September 25, 2024
Alexandra Murphy

A recent study from Harvard Medical School introduced TxGNN, an innovative AI tool designed to identify potential drug candidates for over 17,000 rare and neglected diseases.

The research, published in Natural Medicine Sept. 25, found that TxGNN is nearly 50% more effective at identifying drug candidates and 35% more accurate in predicting contraindications than existing methods.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
What McKinsey learned while creating its generative AI platform
Gen Z are all using AI to get their work done, study finds
Top 5 Azure AI Announcements From Microsoft Ignite 2024
AI In Cybersecurity: Understanding The New Regulatory Framework And What It Means For Businesses
Microsoft’s 10 new AI agents strengthen its enterprise automation lead

Share This Article